CHARACTERIZED BY A DESQUAMATIVE INTERSTITIAL PNEUMONIA WITH GIANT CELLS. COEXISTS WITH SYMPTOMS pdf

Size: px
Start display at page:

Download "CHARACTERIZED BY A DESQUAMATIVE INTERSTITIAL PNEUMONIA WITH GIANT CELLS. COEXISTS WITH SYMPTOMS pdf"

Transcription

1 1: Pneumonia, Desquamative Interstitial GIP is characterized by patchy interstitial chronic inflammation with a centrilobular accentuation, numerous intraalveolar collections of macrophages (as in desquamative interstitial pneumonia), and bizarre syncytial giant cells that often contain macrophages and neutrophils in their cytoplasm (Figs. and ). There is often black. Case Rep Gastrointest Med. Published online Jun This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Symptoms remained virtually unchanged following administration of antibiotics. A final diagnosis of organizing pneumonia OP was made based on findings of intra-alveolar buds of granulation tissue and fibrous thickening of the alveolar walls on pathological examination and patchy consolidations and ground glass opacities on computed tomography. Immediate administration of prednisolone provided rapid, sustained improvement. Although a rare complication, OP is a pulmonary manifestation that requires attention in CD patients. Noninfectious pulmonary diseases associated with CD are uncommon. These associations are generally considered to arise from extraintestinal manifestations of the disease itself and adverse effects to therapeutic drugs prescribed to ameliorate inflammation [ 3 ]. Organizing pneumonia OP is a particular form of pneumonia presenting as diffuse interstitial lung disease that affects the distal bronchioles, respiratory bronchioles, alveolar ducts, and alveolar walls [ 4 â 6 ]. OP appearing with CD is extremely rare. Only a single report has described nonresolving pneumonia in 3 CD patients receiving immunosuppressive agents: Case Report This patient was a year-old man who had previously undergone partial ileal resection due to intestinal obstruction and partial peritonitis at the age of He had since been admitted to other hospitals because of repeated temporary obstructions at the anastomotic site. At the age of 62, the patient was referred to our hospital with recurrent severe abdominal pain and exacerbation of CD. The patient had no history of lung disease, occupational exposures, or extraintestinal manifestations and no family history of CD. Physical examination revealed the following: A small bowel series showed longitudinal ulcers and strictures at the ileal anastomotic site. Colonoscopy and pathological examination of a biopsied ulcer specimen showed moderate to severe inflammatory cell infiltrates with some epithelioid granulomas in the lamina muscularis mucosae and submucosa. Based on these findings, CD was initially diagnosed. Two years later, the patient was admitted to our hospital due to rapid exacerbation of productive cough, accompanied by fever of up to Laboratory investigations showed the following: Low albuminemia was due to severe inflammation and loss of appetite. Chest computed tomography CT revealed patchy consolidations, ground glass opacities, and small nodular opacities, predominantly in the middle, lingula, and bilateral lower lobes Figures 1 b and 1 c. Based on these findings, we considered a diagnosis of bacterial pneumonia due to streptococcal species. Despite antibiotic treatment with intravenous piperacillin-tazobactam and meropenem and supportive care for 14 days, respiratory symptoms remained unimproved and radiographic findings gradually deteriorated. A transbronchial lung biopsy from a right lung lesion showed fibrous thickening of the alveolar wall and intra-alveolar buds of granulation tissue associated with fibroblasts Figure 2. Based on these findings, a final diagnosis of OP associated with CD was made though postinfectious OP could not be completely ruled out. The patient has remained well for a year. Page 1

2 2: Pathology Outlines - Desquamative interstitial pneumonitis (DIP) interstitial pneumonia, desquamative chronic pneumonia with desquamation of large alveolar cells and thickening of the walls of distal air passages; marked by dyspnea and nonproductive cough. double pneumonia that affecting both lungs. To begin with, pneumonia is inflammation of the lungs due to infection. The lungs are two organs in the body that help people breathe. Interstitial pneumonia is a long-term inflammatory lung disease that affects the interstitial connective tissue of the lungs. The inflammation is due to the build up of white blood cells and protein -rich plasma the watery part of blood throughout the alveoli. White blood cells help protect the body against diseases and fight infections. Alveoli are tiny sacs where gases are exchanged in the lungs so that breathing can take place. The inflammation in interstitial pneumonia extends beyond the end of the bronchioles. Bronchioles are small airways that branch off the other small airways connected to the lungs. These other small airways are known as bronchi. If the inflammation lasts long enough it can cause fluid in the lungs to harden, resulting in the production of firm connective tissue scar tissue. The production of this firm tissue is known as fibrosis. There is also collagen formation in the walls of the alveoli. Collagen is a fiber -like protein found in the skin. A cyst is an abnormal lump, swelling, or sac that contains fluid, a part solid material, or a gas, and is covered with a membrane. A membrane is a thin layer of flexible tissue that covers something. As the disease progresses, the bronchi and the walls of the bronchi eventually become widened, the walls of the bronchi are destroyed, and the lungs shrink. When patients with interstitial pneumonia die and the lungs are examined, there are characteristic large cells found lining the alveoli. The giant cells that line the alveoli have multiple nuclei. A nucleus is the structure at the center of a cell. More than one nucleus is known as nuclei. The presence of these large cells in the alveoli is why interstitial pneumonia is also known as giant cell pneumonia. Interstitial pneumonia is most common between the ages of 40 and There are different types of interstitial pneumonia which are each sufficiently different enough from each other to be considered distinct diagnoses. The different types of interstitial pneumonia are described below: This is the most common type of interstitial pneumonia. UIP is a deadly disease that commonly occurs in people 60 years or older that were otherwise in good health. It is not uncommon in the 5th decade of life. Males and females are affected in equal numbers. UIP begins slowly, with inflammation of the alveoli and increased numbers of cells in the walls of the alveoli. As the disease progresses, it becomes more difficult to breath. By the time the diagnosis is made, breathing ability has significantly decreased. The lung tissue will have an abnormal, honeycombed appearance, much like a bee hive. This is due to the disease causing patchy distortion and destruction of the lung tissue structure. The honeycombs are actually holes in the lung that are about one centimeter wide. The presence of honeycombs usually represents the end stage of many forms of lung disease. In about half of UIP patients, x-rays of the lungs, show hazy appearance of ground glass in the lungs. The ground glass appearance is known as ground glass opacities and is usually due to inflammation of the alveoli, thickening of the alveoli walls, or early fibrosis an overgrowth of connective tissue. Small amounts of old fibrosis see above are also present. There is also recent granulation tissue present. Granulation tissue is new connective tissue and tiny blood vessels that is commonly seen on the surfaces of wounds during the healing process. A pneumothorax is the presence of air or gas in the pleural space, causing a lung to collapse. Part of the lung tissue will also look normal in UIP. The pleura is the smooth, moist double layer of flexible tissue that lines the lungs and the chest wall. The pleural space is a thin, fluid-filled opening between the pleura of the lungs and the pleura of the chest wall. Over time, lung size decreases in UIP, which can also be seen on x-ray. On CT scans, a network of more transparent areas known as reticular opacities can be seen, which is due to lung destruction, honeycombing, fibrosis see above, and bronchiectasis. CT scanning is an advanced imaging technique that uses x-rays and computer technology to produce more clear and detailed pictures than a traditional x-ray. Bronchiectasis is irreversible widening and destruction of the walls of the bronchi. It is unclear if bronchiectasis is due to interstitial pneumonia or the frequent bacterial infections that these patients often Page 2

3 experience. These findings are present in almost all patients with UIP and are usually found beneath the pleura and towards the bottom of both sides of the lungs. Remember, the pleura is the smooth, moist double layer of flexible tissue that lines the lungs and the chest wall. This type of interstitial pneumonia occurs in current or past smokers. Current smokers are usually affected in the 30s or 40s and feel out of breath after only mild physical exertion. Although this condition is called pneumonia, there is no evidence that the inflammation is caused by an infection. The lesions in this type of pneumonia are spread throughout the tissue and are usually the same size. There is mild inflammation in the interstitial tissue and fibrosis see last section is present. There are many macrophages present in the alveoli tiny air sacs with a light brown coloring. A macrophage is a type of white blood cell that eats bacteria. Hyperplasia of the lung occurs, which means that there is an increased number of cells present. Chest x-rays generally show less severe changes than in UIP see above. For example, in this type of pneumonia, there is little honeycombing. There is also a decreased amount of oxygen in the blood. This is an uncommon lung disease in which mature lymphocytes and plasma cells build up in the alveoli see above and in the spaces between alveoli. A lymphocyte is a type of white blood cell present in the blood. Plasma is the watery part of blood. LIP occurs in children, but rarely in adults. LIP progresses slowly and leads to the formation of cysts in the lungs. Pulmonary fibrosis can be a long-term complication of patients with LIP and often develops slowly. Respiratory distress has been reported, especially in children with LIP. Lymphoma can also result from lymphoid interstitial pneumonia. Lymphoma is cancer of the lymphatic tissue. The lymphatic system is a system of vessels that drain lymph from all over the body and back into the blood. Lymph is a milky fluid that contains proteins, fats, and white blood cells which help the body fight off diseases. A condition known as pseudolymphoma is a variant of LIP that causes the build-up of harmless abnormal tissue masses. Pseudolymphoma is not a disease, but is an inflammatory reaction to certain known or unknown stimuli. AIP is a type of interstitial pneumonia that comes on suddenly acute and with great severity. It has no known cause. AIP is also known as severe interstitial lung disease, idiopathic adult respiratory distress syndrome, and Hamman-Rich Disease. CIP is a type of interstitial pneumonia with the following characteristics. First is the presence of polyps that contain granulation tissue in the tubular space of bronchioles the smallest airways of the lungs and alveolar ducts. The alveolar ducts are part of the airway passages that are positioned away from the bronchioles. Polyps are a type of growth that projects from the lining of mucous membranes. A mucous membrane is one of four major types of thin sheets of tissue that line or cover various parts of the body. Granulation tissue is a combination of new connective tissue and tiny blood vessels. The second characteristic of CIP is the presence of patchy areas of pneumonia, consisting largely of mononuclear cells and foamy macrophages a type of white blood cell that eats bacteria. Mononuclear cells are cells with one nucleus. RB-ILD is a mild type of interstitial lung disease seen in heavy cigarette smokers. Symptoms include cough, phlegm production, and uncomfortable breathing. Two thirds of patients have crackles that can be heard when the doctor taps the chest area and listen for sounds. Pulmonary function tests show a restrictive defect. After the patient stops smoking, damage in the lungs seen on CT scan appears to remain stable or resolve slowly without progressing to lung disease with fibrosis. NSIP is a type of interstitial pneumonia that cannot be classified into one of the above types. NSIP begins somewhat quickly. The signs and symptoms of interstitial pneumonia include progressively worse discomfort while breathing, fever, occasional wheezing, blue discoloration of the skin, and an abnormal enlargement of the end of the fingers known as clubbing. There also tends to be a non-productive cough for one to three years. For people with lymphoid interstitial pneumonia LIP, enlargement of lymph nodes or lymph vessels may occur. Lymph nodes are small egg shaped structures in the body that help fight against infection. Lymph vessels are tube-shaped structures that carry lymph throughout the body. People with LIP may also experience enlargement of the liver, spleen, and parotid glands. Page 3

4 3: Organizing Pneumonia in a Patient with Quiescent Crohn's Disease Desquamative interstitial pneumonia (DIP) is characterised by the accumulation of numerous pigmented macrophages within most of the distal airspace of the lung and, sometimes, the presence of giant cells. Diagnosis of DIP is not easy and requires surgical lung biopsy. DIP is usually associated with. RB-ILD and DIP are different entities and not two junctures in a continuum, based on their distinct clinical presentation, radiographic features, histology, response to treatment, and prognosis. Histologically, DIP is characterized by an alveolar accumulation of macrophages followed by interstitial inflammation and fibrosis. It usually portends a poorer prognosis. The original authors also did not report the distinctive association with smoking which was first highlighted by Carrington et al. The characteristic findings of pigmented macrophages, therefore, have a distinct bronchiolocentric distribution with centrilobular ground-glass opacities in chest imaging. The extensive alveolar infiltration of macrophages renders them an eosinophilic stain due to the abundant eosinophilic cytoplasm of the macrophages. Radiologically, cystic spaces may be present in areas of ground glass opacities. Those small cystic air spaces seen in chest imaging in DIP have been shown to correlate histologically with dilated alveolar ducts and bronchiectasis. Toward late-stage disease, production of transforming growth factor beta-1 results in fibrosis around alveolar interstitium. Unlike usual interstitial pneumonia, however, fibroblastic foci are almost never seen. Multinucleated giant cells are also often reported. History and Physical An overlap of clinical and histopathological features are common among smoking-related interstitial pneumonia. Individuals with a history of relevant exposure to cigarettes, inhalational drugs of abuse, and occupational risk factors commonly present with a dry cough and exercise-induced shortness of breath. Although childhood disease has been rarely reported as mentioned above, the most common age of presentation is 40 to 60 years. Hemoptysis is very rare. Evaluation Peripheral blood may reveal an increase in neutrophil and eosinophil count. Pulmonary function tests show a restrictive defect, with impaired diffusion capacity unlike usual obstructive pattern in respiratory bronchiolitis. Chest x-ray may show a reticulonodular infiltrate in lower lung zones but appears fairly subtle and nonspecific. High-resolution CT chest is the imaging modality of choice. It shows diffuse bilateral lower lobe predominant ground glass changes in a homogenous distribution, and without honeycombing- the last two features distinguishing it from usual interstitial pneumonia or idiopathic pulmonary fibrosis. In progressive disease, cysts and traction bronchiectasis may be seen, but it is not exclusively subpleural. However advanced DIP is reported to be indistinguishable from NSIP with a temporally uniform pattern of fibrosis beyond the initial accumulation of alveolar macrophages. Interestingly in a study reported by Cartier et al. A surgical lung biopsy is the gold standard of diagnosis. In recent years, transbronchial cryobiopsy is being explored as an alternative diagnostic approach with an increase in sample size by non-invasive means. Similarly if associated with specific occupational exposures, avoidance of exposure is also key to preventing disease progression. Systemic corticosteroid therapy over months has been reported as the most effective pharmacologic intervention. With corticosteroids and immunosuppressive therapy azathioprine being the most commonly used agent, most patients remain stable or improve with reports of even complete recovery. Finally, with progressive and severe lung disease causing hypoxemia, pulmonary hypertension, severe reduction in TLC or DLCO, lung transplantation evaluation is indicated [1] [26] ; although, there are reports of recurrence of DIP post lung transplantation. Idiopathic pulmonary fibrosis Idiopathic nonspecific interstitial pneumonia NSIP Cryptogenic organizing pneumonia Acute interstitial pneumonia formerly Hamman-Rich syndrome Idiopathic lymphoid interstitial pneumonia. Page 4

5 4: Interstitial Pneumonia: Signs, Symptoms, & Treatment- Desquamative interstitial pneumonia (DIP) Intra-alveolar macrophage accumulation Not a true desquamation of epithelial cells Almost always seen in smokers Clinical. Background Interstitial pneumonias are a confusing and frustrating set of diseases both for the treating physician and for the diagnostic pathologist. One source of the confusion has been the lack of overlapping terms that treating physicians and pathologists use. For example, idiopathic pulmonary fibrosis IPF is a clinical term describing a slowly progressive, chronic interstitial pneumonia. To complicate matters even further, European clinicians utilize the term cryptogenic fibrosing alveolitis for IPF. Pathologists also share in the confusion. Terms that were commonly used by pathologists just a few years ago have also undergone an evolution. Bronchiolitis obliterans with organizing pneunomina BOOP is no longer used because it has been considered a mixture of terms. Lymphocytic interstitial pneumonia LIP is now considered a lymphoproliferative disease. Giant cell interstitial pneumonitis GIP is now considered a hard metal pneumoconiosis. The symptoms vary for each of the pneumonias but most are characterized by a slowly progressive shortness of breath. Chest radiographs reveal a hazy ground glass appearance with linear opacities. Most of the diseases are progressive and are treated with corticosteroids. Usual interstitial pneumonia UIP is a form of lung disease characterized by progressive scarring of both lungs. The scarring fibrosis involves the supporting framework interstitium of the lung. UIP is thus classified as a form of interstitial lung disease. The term "usual" refers to the fact that UIP is the most common form of interstitial fibrosis. The term used for UIP in the British literature is cryptogenic fibrosing alveolitis, a term that has fallen out of favor since the basic underlying pathology is now thought to be fibrosis, not inflammation. Causes The cause of the scarring in UIP may be known or unknown. The latter situation is more common. Symptoms The typical symptoms of UIP are progressive shortness of breath and cough for a period of months. In some patients, UIP is diagnosed only when a more acute disease supervenes and brings the patient to medical attention. Prognosis Regardless of etiology, UIP is relentlessly progressive, usually leading to respiratory failure and death. Some patients do well for a prolonged period of time, but then deteriorate rapidly because of a superimposed acute illness so-called "accelerated UIP". The outlook for long-term survival is poor. In most studies, the median survival is 3 to 4 years. How is interstitial lung disease treated? The choice of treatment depends upon a number of factors including the cause of the interstitial lung disease and the overall health status of the patient. Most commonly, corticosteroid drugs are given in an attempt to reduce the inflammation. Sometimes, immune-suppressing drugs, such as asazathioprine Imuran or cyclophosphamide Cytoxan are also given, either in combination with steroids or following a course of steroid treatment. Smoking cessation is critical for those with interstitial lung disease. Pneumonia What is pneumonia? Pneumonia is an infection of the tiny air sacs of the lungs. There are many different types of pneumonia, which can range from mild to severe. An incurable, deadly lung disorder. Medical Marijuana Medical marijuana should never be smoked by anyone with lung problems. My suggestion is that you acquire a Sativa x Indica hybrid and then make yourself a whole plant tincture. Place a drop under the tongue twice a day to start. These you should also make yourself using: Or if making an oil: There are articles on our website: Acquire organically grown medical marijuana free of any pathogens. Make your own whole plant extracts. This way you will be taking the best medicine possible. General principles and recommendations. Sumikawa H, et al Human Pathology 39 9: Coalition for Pulmonary Fibrosis: Page 5

6 5: Interstitial Pneumonia In desquamative interstitial pneumonia, the biopsy usually shows a distinctive pattern of widespread and evenly distributed lung inflammation. The most striking feature of the lung biopsy is the presence of. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Symptoms remained virtually unchanged following administration of antibiotics. A final diagnosis of organizing pneumonia OP was made based on findings of intra-alveolar buds of granulation tissue and fibrous thickening of the alveolar walls on pathological examination and patchy consolidations and ground glass opacities on computed tomography. Immediate administration of prednisolone provided rapid, sustained improvement. Although a rare complication, OP is a pulmonary manifestation that requires attention in CD patients. Noninfectious pulmonary diseases associated with CD are uncommon. These associations are generally considered to arise from extraintestinal manifestations of the disease itself and adverse effects to therapeutic drugs prescribed to ameliorate inflammation [ 3 ]. Organizing pneumonia OP is a particular form of pneumonia presenting as diffuse interstitial lung disease that affects the distal bronchioles, respiratory bronchioles, alveolar ducts, and alveolar walls [ 4 â 6 ]. OP appearing with CD is extremely rare. Only a single report has described nonresolving pneumonia in 3 CD patients receiving immunosuppressive agents: Case Report This patient was a year-old man who had previously undergone partial ileal resection due to intestinal obstruction and partial peritonitis at the age of He had since been admitted to other hospitals because of repeated temporary obstructions at the anastomotic site. At the age of 62, the patient was referred to our hospital with recurrent severe abdominal pain and exacerbation of CD. The patient had no history of lung disease, occupational exposures, or extraintestinal manifestations and no family history of CD. Physical examination revealed the following: A small bowel series showed longitudinal ulcers and strictures at the ileal anastomotic site. Colonoscopy and pathological examination of a biopsied ulcer specimen showed moderate to severe inflammatory cell infiltrates with some epithelioid granulomas in the lamina muscularis mucosae and submucosa. Based on these findings, CD was initially diagnosed. Two years later, the patient was admitted to our hospital due to rapid exacerbation of productive cough, accompanied by fever of up to Laboratory investigations showed the following: Low albuminemia was due to severe inflammation and loss of appetite. Chest computed tomography CT revealed patchy consolidations, ground glass opacities, and small nodular opacities, predominantly in the middle, lingula, and bilateral lower lobes Figures 1 b and 1 c. Based on these findings, we considered a diagnosis of bacterial pneumonia due to streptococcal species. Despite antibiotic treatment with intravenous piperacillin-tazobactam and meropenem and supportive care for 14 days, respiratory symptoms remained unimproved and radiographic findings gradually deteriorated. A transbronchial lung biopsy from a right lung lesion showed fibrous thickening of the alveolar wall and intra-alveolar buds of granulation tissue associated with fibroblasts Figure 2. Based on these findings, a final diagnosis of OP associated with CD was made though postinfectious OP could not be completely ruled out. The patient has remained well for a year. Laboratory findings on admission. Progressive pulmonary symptoms and manifestations were seen during scheduled ADA maintenance therapy. Treatment with prednisolone induced rapid, sustained improvements. Discussion CD often shows extraintestinal manifestations such as uveitis and ankylosing spondylitis [ 9 ]. On the other hand, primary lung involvement is rare and reportedly includes bronchiolitis obliterans organizing pneumonia BOOP, pulmonary interstitial emphysema, desquamative interstitial pneumonia, nonspecific interstitial pneumonia, fibrosing alveolitis, and eosinophilic pneumonitis [ 2, 3 ]. Lung involvement can also be secondary to the drug used to treat CD [ 10 ]. In this type of idiopathic diffuse interstitial lung disease, granulation tissue obstructs the alveolar ducts and alveolar spaces and chronic inflammation arise in the adjacent alveoli [ 5, 6 ]. Pulmonary interstitial emphysema is characterized by air trapping outside the normal air passages and inside the connective tissue of the Page 6

7 peribronchovascular sheaths, interlobular septa, and visceral pleura; this disease entity is more frequent in premature infants who require mechanical ventilation for severe lung disease [ 12 ]. Desquamative interstitial pneumonia is a chronic lung inflammation characterized by mononuclear cell infiltration of the airspaces. It occurs almost exclusively in current or former cigarette smokers [ 13 ]. Fibrosing alveolitis is characterized by inflammation and thickening of the alveolar walls and usually occurs in individuals over the age of 40 years [ 14 ]. Eosinophilic pneumonitis is a disease characterized by accumulation of eosinophils in bronchoalveolar lavage and lung tissue [ 15 ]. In the present case, the final diagnosis of OP associated with CD was made based on the pathological and CT findings and the clinical course [ 16 â 18 ]. However, in terms of the clinical features, postpneumonic OP and secondary OP, these are actually fairly similar. Differentiating postpneumonic OP from secondary OP based on the radiographic findings was difficult. Despite the use of wide-spectrum antibiotics, respiratory symptoms persisted and findings on chest radiography gradually deteriorated. In general, in the early period of postpneumonic OP, antibiotics therapies are partially effective and yield some degree of improvement in symptoms and radiological findings [ 19, 20 ]. Based on the above, we concluded that secondary OP was more likely than postpneumonic OP. Consensus is currently lacking regarding a definitive approach to diagnosing drug-induced lung disease. In a few cases, drug-induced lung disease can show a clinical course and radiographic findings like OP [ 24, 25 ]. In the present case, at disease onset, the patient was immediately given prednisolone, which provided rapid and sustained improvement. The prednisolone was subsequently tapered while ADA and mesalazine were continued. As a result, the patient has remained well without recurrence of OP. These results suggest that this lung disorder was unlikely to present a drug-induced lung disease and was instead more likely to be OP associated with CD. For patients with progressive symptoms of cryptogenic organizing pneumonia COP and diffuse radiographic changes, initial therapy with oral glucocorticoids is recommended for promising clinical outcomes [ 26, 27 ]. However, one case has been described in which initial treatment with glucocorticoids led to poor outcome, whereas a dramatic response to infliximab was seen. Interestingly, OP cases have not been known to be associated with the disease activity of IBD [ 2, 11, 28 ]. In conclusion, although OP is a rare complication, due vigilance is required regarding the occurrence of pulmonary symptoms and manifestations in CD and IBD patients. Competing Interests The authors declare that there is no conflict of interests regarding the publication of this paper. Corley III, and M. Page 7

8 6: Organizing Pneumonia in a Patient with Quiescent Crohnâ s Disease Three cases of an unusual interstitial pneumonia, designated by Liebow as giant cell interstitial pneumonia, were encountered by us. Dyspnea, weight loss, cough, chest pain, rales in the lungs and clubbing of the fingers were the frequently observed clinical features. Choon Sik Park, M. This article has been cited by other articles in PMC. There are few reports about the clinical features of NIP. Methods The pathologic slides of 66 patients having open lung biopsy OLB for the differential diagnosis of interstitial lung diseases ILD from to were reviewed. Seven cases were confirmed as NIP. Results Six patients with NIP were female. The median age was 56 years. Mean duration of symptoms was 4 months. Five patients had systemic flu-like symptoms. Diffusion capacity of carbonmonoxide DLCO decreased markedly. In bronchoalveolar lavage BAL, total cell counts elevated about three times of normal value. On differntial counts of BAL cells, lymphocytes, neutrophils and eosinophils were higher than those of normal controls. The prominent finding of chest radiology was bilaterally patchy opacifications in parenchyme of lower lung zones. The average period from diagnosis to the last follow-up was Five patients were clinically recovered to the previously well-being state. They also had characteristic findings of radiology and their prognosis seems to be better than UIP. Hamman and Rich reported the clinical and pathologic findings of four cases, who expired due to a fulminant pulmonary fibrosis with rapidly progessing course in 1. Thereafter, many cases of diffuse interstitial pneumonias with chronic courses have been reported. Although the terminology has been used inconsistently, IPF represents the interstitial penumonias without any evidence of underlying causes or other disease. In, Liebow and carrington classified interstitial pneumonias into five subcategories by pathologic findings, usual interstitial pneumonia UIP, desquamative interstitial pneumonia DIP, bronchiolits with interstitial pneumonia BIP, lymphocytic interstitial pneumonia LIP and giant cell interstitial pneumonia GIP 2, 3. In, Katzenstein 4 identified acute interstitial pneumonia AIP as a new subcategory of fibroblasts is a main component in AIP, whereas the dense deposition of collagens is prominent in UPI. The clinical feature to differentiate NIP from UIP is that the former seems to have a better prognosis than the latter. However, there have been few reports about the clinical features of NIP till now. We firstly reported clinical features of three cases at the 77th Conference on Tuberculosis and Respiratory Diseases of Korea in 6. Because of the shortage of clincal data so far, we summarized the clinical features, radiologic and pathologic findings of seven patients with NIP. Study Population Study population was composed of 66 patients having open lung biopsy OLB for the differential diagnosis of interstitial lung diseases ILD from to For pathologic proof, all pathologic specimens were reviewed by two pathologists in our hospital. NIP is characterized by a variable degree of intersitial inflammation with or without fibrosis. However, it appeared temporally uniform within each case and areas of honeycombing were not found. Histologic features for a specific category of interstitial pneumonia were not present. Group I was characterized by a cellular interstitial pneumonia with littly fibrosis. The interstitial infiltrate was minimal to mild and consisted of small lymphocytes Fig. There were patch involvement and accentuation around bronchioles. Group II was characterized by a cellular interstitial pneumonia with significant fibrosis Fig. The alveolar septa were widened by cellular infiltrations, which consisted of lymphocytes, plasma cells and a few eosinophils. An area of germinal center formation was noted. There was a marked hyperplasia of alveolar lining cells. The fibroblasts were composed of mature collagen and proliferating fibroblasts. Large numbers of intraalveolar macrophages and fibroblast foci were found. Group III was characterized by architectural derangement due to dense interstitial collagenous fibrosis and less degree of inflammation Fig. This process was diffuse in one case and patchy in the other case. The alveolar septa were markedly thickened, resulting in narrowing of air spaces. The alveolar lining cells were hyperplastic and alveolar spaces were filled with alveolar macrophages. Areas of patchy interstitial infiltrate were noted, but their degree was mininal compared to that of group II. Page 8

9 7: Idiopathic interstitial pneumonias Radiology Reference Article Lymphocytic interstitial pneumonia is a rare idiopathic interstitial pneumonia characterized by infiltration of alveoli and alveolar septa with small lymphocytes and varying numbers of plasma cells. Non-necrotizing, poorly formed granulomas may be present but are usually rare and inconspicuous. Page 9

10 Bls instructor manual Roof assemblies Amputation Surgery and Rehabilitation The Modest Memoir of a Yankee Yenta Living and dying in the / Barrier calculations. image charge. A History of US: Book Three The revolution in anthropology How landscapes change Marriage, death, and estate notices from Georgetown, S.C. newspapers, Applied dynamics and mechanisms Tut nsfas application form 2018 Building type basics for elementary and secondary schools Discontented Miracle Sex education, life skills education and nutrition and health education. Electing the United Kingdom Parliament New complete walker College life in the old South Traktor 2 bible 2014 edition Nuclear Powerplant Security and Anti-terrorism Act of Testing of combinational circuits Use of military tribunals to try suspected terrorists is not justified the St. Louis post-dispatch The Do-It-Yourself Coffins for Pets and People Classical conversations 4th edition updates Free but regulated Muslim and Christian Reflections on Peace Public international air transportation law in a new era Appropriations, Department of State, 1927 The wedding rooster Matthew arnold study of poetry Physical science grade 11 study guides caps Pennsylvania guide to real estate licensing examinations for salespersons and brokers Fern growers manual Illustrating the past in early modern England Aeroassisted orbital transfer Human Fact User Syst Interface: Advanced reservoir management and engineering German festivals in Hermann The learning region disconnect Here begins the tale of the marvellous blue mouse Page 10

Liebow and Carrington's original classification of IIP

Liebow and Carrington's original classification of IIP Liebow and Carrington's original classification of IIP-- 1969 Eric J. Stern MD University of Washington UIP Usual interstitial pneumonia DIP Desquamative interstitial pneumonia BIP Bronchiolitis obliterans

More information

Outline Definition of Terms: Lexicon. Traction Bronchiectasis

Outline Definition of Terms: Lexicon. Traction Bronchiectasis HRCT OF IDIOPATHIC INTERSTITIAL PNEUMONIAS Disclosures Genentech, Inc. Speakers Bureau Tadashi Allen, MD University of Minnesota Assistant Professor Diagnostic Radiology 10/29/2016 Outline Definition of

More information

Usual Interstitial pneumonia and Nonspecific Interstitial Pneumonia. Nitra and the Gangs.

Usual Interstitial pneumonia and Nonspecific Interstitial Pneumonia. Nitra and the Gangs. Usual Interstitial pneumonia and Nonspecific Interstitial Pneumonia Nitra and the Gangs. บทน ำและบทท ๓, ๑๐, ๑๒, ๑๓, ๑๔, ๑๕, ๑๗ Usual Interstitial Pneumonia (UIP) Most common & basic pathologic pattern

More information

Financial disclosure COMMON DIAGNOSES IN HRCT. High Res Chest HRCT. HRCT Pre test. I have no financial relationships to disclose. Anatomy Nomenclature

Financial disclosure COMMON DIAGNOSES IN HRCT. High Res Chest HRCT. HRCT Pre test. I have no financial relationships to disclose. Anatomy Nomenclature Financial disclosure I have no financial relationships to disclose. Douglas Johnson D.O. Cardiothoracic Imaging Gaston Radiology COMMON DIAGNOSES IN HRCT High Res Chest Anatomy Nomenclature HRCT Sampling

More information

INTERSTITIAL LUNG DISEASE. Radhika Reddy MD Pulmonary/Critical Care Long Beach VA Medical Center January 5, 2018

INTERSTITIAL LUNG DISEASE. Radhika Reddy MD Pulmonary/Critical Care Long Beach VA Medical Center January 5, 2018 INTERSTITIAL LUNG DISEASE Radhika Reddy MD Pulmonary/Critical Care Long Beach VA Medical Center January 5, 2018 Interstitial Lung Disease Interstitial Lung Disease Prevalence by Diagnosis: Idiopathic Interstitial

More information

NONE OVERVIEW FINANCIAL DISCLOSURES UPDATE ON IDIOPATHIC PULMONARY FIBROSIS/IPF (UIP) FOR PATHOLOGISTS. IPF = Idiopathic UIP Radiologic UIP Path UIP

NONE OVERVIEW FINANCIAL DISCLOSURES UPDATE ON IDIOPATHIC PULMONARY FIBROSIS/IPF (UIP) FOR PATHOLOGISTS. IPF = Idiopathic UIP Radiologic UIP Path UIP UPDATE ON IDIOPATHIC PULMONARY FIBROSIS/IPF () FOR PATHOLOGISTS Thomas V. Colby, M.D. Professor of Pathology (Emeritus) Mayo Clinic Arizona FINANCIAL DISCLOSURES NONE OVERVIEW IPF Radiologic Dx Pathologic

More information

Differential diagnosis

Differential diagnosis Differential diagnosis Idiopathic pulmonary fibrosis (IPF) is part of a large family of idiopathic interstitial pneumonias (IIP), one of four subgroups of interstitial lung disease (ILD). Differential

More information

Restrictive lung diseases

Restrictive lung diseases Restrictive lung diseases Restrictive lung diseases are diseases that affect the interstitium of the lung. Interstitium of the lung is the very thin walls surrounding the alveoli, it s formed of epithelium

More information

Non-neoplastic Lung Disease II

Non-neoplastic Lung Disease II Pathobasic Non-neoplastic Lung Disease II Spasenija Savic Prince Pathology Program Systematic approach to surgical lung biopsies with ILD Examples (chronic ILD): Idiopathic interstitial pneumonias: UIP,

More information

11/10/2014. Multi-disciplinary Approach to Diffuse Lung Disease: The Imager s Perspective. Radiology

11/10/2014. Multi-disciplinary Approach to Diffuse Lung Disease: The Imager s Perspective. Radiology Multi-disciplinary Approach to Diffuse Lung Disease: The Imager s Perspective Radiology Pathology Clinical 1 Role of HRCT Diagnosis Fibrosis vs. inflammation Next step in management Response to treatment

More information

International consensus statement on idiopathic pulmonary fibrosis

International consensus statement on idiopathic pulmonary fibrosis Eur Respir J 2001; 17: 163 167 Printed in UK all rights reserved Copyright #ERS Journals Ltd 2001 European Respiratory Journal ISSN 0903-1936 PERSPECTIVE International consensus statement on idiopathic

More information

HYPERSENSITIVITY PNEUMONITIS

HYPERSENSITIVITY PNEUMONITIS HYPERSENSITIVITY PNEUMONITIS A preventable fibrosis MOSAVIR ANSARIE MB., FCCP INTERSTITIAL LUNG DISEASES A heterogeneous group of non infectious, non malignant diffuse parenchymal disorders of the lower

More information

5/9/2015. Multi-disciplinary Approach to Diffuse Lung Disease: The Imager s Perspective. No, I am not a pulmonologist! Radiology

5/9/2015. Multi-disciplinary Approach to Diffuse Lung Disease: The Imager s Perspective. No, I am not a pulmonologist! Radiology Multi-disciplinary Approach to Diffuse Lung Disease: The Imager s Perspective No, I am not a pulmonologist! Radiology Pathology Clinical 1 Everyone needs a CT Confidence in diagnosis Definitive HRCT +

More information

Case Presentations in ILD. Harold R. Collard, MD Department of Medicine University of California San Francisco

Case Presentations in ILD. Harold R. Collard, MD Department of Medicine University of California San Francisco Case Presentations in ILD Harold R. Collard, MD Department of Medicine University of California San Francisco Outline Overview of diagnosis in ILD Definition/Classification High-resolution CT scan Multidisciplinary

More information

Acute and Chronic Lung Disease

Acute and Chronic Lung Disease KATHOLIEKE UNIVERSITEIT LEUVEN Faculty of Medicine Acute and Chronic Lung Disease W De Wever, JA Verschakelen Department of Radiology, University Hospitals Leuven, Belgium Clinical utility of HRCT To detect

More information

Radiologic Approach to Smoking Related Interstitial Lung Disease

Radiologic Approach to Smoking Related Interstitial Lung Disease Radiologic Approach to Smoking Related Interstitial Lung Disease Poster No.: C-1854 Congress: ECR 2013 Type: Educational Exhibit Authors: K.-N. Lee, J.-Y. Han, E.-J. Kang, J. Kang; Busan/KR Keywords: Toxicity,

More information

Diagnosing Idiopathic Pulmonary Fibrosis on Evidence-Based Guidelines

Diagnosing Idiopathic Pulmonary Fibrosis on Evidence-Based Guidelines Diagnosing Idiopathic Pulmonary Fibrosis on Evidence-Based Guidelines Rebecca Keith, MD Assistant Professor, Division of Pulmonary and Critical Care Medicine National Jewish Health, Denver, CO Objectives

More information

HRCT in Diffuse Interstitial Lung Disease Steps in High Resolution CT Diagnosis. Where are the lymphatics? Anatomic distribution

HRCT in Diffuse Interstitial Lung Disease Steps in High Resolution CT Diagnosis. Where are the lymphatics? Anatomic distribution Steps in High Resolution CT Diagnosis Pattern of abnormality Distribution of disease Associated findings Clinical history Tomás Franquet MD What is the diagnosis? Hospital de Sant Pau. Barcelona Secondary

More information

Idiopathic Pulmonary of Care

Idiopathic Pulmonary of Care Chapter 6.1 Living Medical etextbook A Digital Tool at the Point of Care From Projects In Knowledge Pulmonology Idiopathic Pulmonary Fibrosis @Point of Care IPF Case Study: Typical Presentation, Role of

More information

June 2013 Pulmonary Case of the Month: Diagnosis Makes a Difference. Lewis J. Wesselius, MD 1 Henry D. Tazelaar, MD 2

June 2013 Pulmonary Case of the Month: Diagnosis Makes a Difference. Lewis J. Wesselius, MD 1 Henry D. Tazelaar, MD 2 June 2013 Pulmonary Case of the Month: Diagnosis Makes a Difference Lewis J. Wesselius, MD 1 Henry D. Tazelaar, MD 2 Departments of Pulmonary Medicine 1 and Laboratory Medicine and Pathology 2 Mayo Clinic

More information

I don t need you. Disclosure Statement. Pathology Approach to ILD 11/5/2016. Kirk D. Jones, MD UCSF Dept of Pathology

I don t need you. Disclosure Statement. Pathology Approach to ILD 11/5/2016. Kirk D. Jones, MD UCSF Dept of Pathology Pathology Approach to ILD Disclosure Statement Relevant financial relationships with a commercial interest: Boeringer Ingleheim, speaker Kirk D. Jones, MD UCSF Dept of Pathology kirk.jones@ucsf.edu I don

More information

A Review of Interstitial Lung Diseases

A Review of Interstitial Lung Diseases Outline A Review of Interstitial Lung Diseases Paul J. Wolters, MD Associate Professor Department of Medicine University of California San Francisco Overview of diagnosis in ILD Why it is important Definition/Classification

More information

Bronkhorst colloquium Interstitiële longziekten. Katrien Grünberg, klinisch patholoog

Bronkhorst colloquium Interstitiële longziekten. Katrien Grünberg, klinisch patholoog Bronkhorst colloquium 2013-2014 Interstitiële longziekten De pathologie achter de CT Katrien Grünberg, klinisch patholoog K.grunberg@vumc.nl Preparing: introduction and 3 cases The introduction on microscopic

More information

Case 1 : Question. 1.1 What is the intralobular distribution? 1. Centrilobular 2. Perilymphatic 3. Random

Case 1 : Question. 1.1 What is the intralobular distribution? 1. Centrilobular 2. Perilymphatic 3. Random Interesting case Case 1 Case 1 : Question 1.1 What is the intralobular distribution? 1. Centrilobular 2. Perilymphatic 3. Random Case 1: Answer 1.1 What is the intralobular distribution? 1. Centrilobular

More information

Manish Powari Regional Training Day 10/12/2014

Manish Powari Regional Training Day 10/12/2014 Manish Powari Regional Training Day 10/12/2014 Large number of different types of Interstitial Lung Disease (ILD). Most are very rare Most patients present with one of a smaller number of commoner diseases

More information

A Review of Interstitial Lung Diseases. Paul J. Wolters, MD Associate Professor Department of Medicine University of California San Francisco

A Review of Interstitial Lung Diseases. Paul J. Wolters, MD Associate Professor Department of Medicine University of California San Francisco A Review of Interstitial Lung Diseases Paul J. Wolters, MD Associate Professor Department of Medicine University of California San Francisco Outline Overview of diagnosis in ILD Why it is important Definition/Classification

More information

Histopathologic Approach to Interstitial Lung Disease

Histopathologic Approach to Interstitial Lung Disease Histopathologic Approach to Interstitial Lung Disease Kirk D. Jones, MD UCSF Dept of Pathology kirk.jones@ucsf.edu Disclosures I have nothing to disclose 1 Why? Much of interstitial lung disease biopsies

More information

Case 4 History. 58 yo man presented with prox IP joint swelling 2 months later pain and swelling in multiple joints Chest radiograph: bi-basilar

Case 4 History. 58 yo man presented with prox IP joint swelling 2 months later pain and swelling in multiple joints Chest radiograph: bi-basilar Case 4 History 58 yo man presented with prox IP joint swelling 2 months later pain and swelling in multiple joints Chest radiograph: bi-basilar basilar infiltrates suggestive of pulmonary fibrosis Open

More information

Bronchoalveolar Lavage and Histopathologic Diagnosis Based on Biopsy

Bronchoalveolar Lavage and Histopathologic Diagnosis Based on Biopsy Idiopathic Pulmonary Fibrosis Bronchoalveolar Lavage and Histopathologic Diagnosis Based on Biopsy JMAJ 46(11): 469 474, 2003 Yukihiko SUGIYAMA Professor, Division of Pulmonary Medicine, Department of

More information

PULMONARY TUBERCULOSIS RADIOLOGY

PULMONARY TUBERCULOSIS RADIOLOGY PULMONARY TUBERCULOSIS RADIOLOGY RADIOLOGICAL MODALITIES Medical radiophotography Radiography Fluoroscopy Linear (conventional) tomography Computed tomography Pulmonary angiography, bronchography Ultrasonography,

More information

Replacement of air with fluid, inflammatory. cells or cellular debris. Parenchymal, Interstitial (Restrictive) and Vascular Diseases.

Replacement of air with fluid, inflammatory. cells or cellular debris. Parenchymal, Interstitial (Restrictive) and Vascular Diseases. Parenchymal, Interstitial (Restrictive) and Vascular Diseases Alain C. Borczuk, M.D. Dept of Pathology Replacement of air with fluid, inflammatory cells Pulmonary Edema Pneumonia Hemorrhage Diffuse alveolar

More information

SESSION IV: MECHANISMS OF HUMAN DISEASE: LABORATORY SESSIONS PULMONARY PATHOLOGY I. December 5, 2012

SESSION IV: MECHANISMS OF HUMAN DISEASE: LABORATORY SESSIONS PULMONARY PATHOLOGY I. December 5, 2012 SESSION IV: MECHANISMS OF HUMAN DISEASE: LABORATORY SESSIONS PULMONARY PATHOLOGY I December 5, 2012 FACULTY COPY GOAL: Describe the basic morphologic and pathophysiologic changes in various conditions

More information

An Image Repository for Chest CT

An Image Repository for Chest CT An Image Repository for Chest CT Francesco Frajoli for the Chest CT in Antibody Deficiency Group An Image Repository for Chest CT he Chest CT in Antibody Deficiency Group is an international and interdisciplinary

More information

SCLERODERMA LUNG DISEASE: WHAT THE PATIENT SHOULD KNOW

SCLERODERMA LUNG DISEASE: WHAT THE PATIENT SHOULD KNOW SCLERODERMA LUNG DISEASE: WHAT THE PATIENT SHOULD KNOW Lung disease can be a serious complication of scleroderma. The two most common types of lung disease in patients with scleroderma are interstitial

More information

How to identify interstitial pneumonias.

How to identify interstitial pneumonias. How to identify interstitial pneumonias. Poster No.: C-0804 Congress: ECR 2014 Type: Educational Exhibit Authors: S. claret loaiza, M. C. Cañete Moslero, R. Carreño Gonzalez, C. de la Torre; Malaga/ES

More information

Imaging Small Airways Diseases: Not Just Air trapping. Eric J. Stern MD University of Washington

Imaging Small Airways Diseases: Not Just Air trapping. Eric J. Stern MD University of Washington Imaging Small Airways Diseases: Not Just Air trapping Eric J. Stern MD University of Washington What we are discussing SAD classification SAD imaging with MDCT emphasis What is a small airway? Airway with

More information

Challenges in the Diagnosis of Interstitial Lung Disease

Challenges in the Diagnosis of Interstitial Lung Disease Challenges in the Diagnosis of Interstitial Lung Disease Kirk D. Jones, MD UCSF Dept. of Pathology kirk.jones@ucsf.edu Overview New Classification of IIP Prior classification Modifications for new classification

More information

TBLB is not recommended as the initial biopsy option in cases of suspected IPF and is unreliable in the diagnosis of rare lung disease (other than

TBLB is not recommended as the initial biopsy option in cases of suspected IPF and is unreliable in the diagnosis of rare lung disease (other than TBLB is not recommended as the initial biopsy option in cases of suspected IPF and is unreliable in the diagnosis of rare lung disease (other than PAP) BAL is not required as a diagnostic tool in patients

More information

Cryptogenic Organizing Pneumonia Diagnosis Approach Based on a Clinical-Radiologic-Pathologic Consensus

Cryptogenic Organizing Pneumonia Diagnosis Approach Based on a Clinical-Radiologic-Pathologic Consensus Cryptogenic Organizing Pneumonia Diagnosis Approach Based on a Clinical-Radiologic-Pathologic Consensus Poster No.: C-1622 Congress: ECR 2012 Type: Scientific Exhibit Authors: C. Cordero Lares, E. Zorita

More information

Pathologic Assessment of Interstitial Lung Disease

Pathologic Assessment of Interstitial Lung Disease Pathologic Assessment of Interstitial Lung Disease Dry and itchy? It could be eczema or fungal infection. We don t need to worry, the drugs aren t that dangerous. Kirk D. Jones, MD UCSF Dept. of Pathology

More information

Disclosures. Fibrotic lung diseases: Basic Principles, Common Problems, and Reporting. Relevant financial relationships: None. Off-label usage: None

Disclosures. Fibrotic lung diseases: Basic Principles, Common Problems, and Reporting. Relevant financial relationships: None. Off-label usage: None Fibrotic lung diseases: Basic Principles, Common Problems, and Reporting Brandon T. Larsen, MD, PhD Senior Associate Consultant Department of Laboratory Medicine and Pathology Mayo Clinic Arizona Arizona

More information

ARTICLE IN PRESS. Ahuva Grubstein a, Daniele Bendayan b, Ithak Schactman c, Maya Cohen a, David Shitrit b, Mordechai R. Kramer b,

ARTICLE IN PRESS. Ahuva Grubstein a, Daniele Bendayan b, Ithak Schactman c, Maya Cohen a, David Shitrit b, Mordechai R. Kramer b, Respiratory Medicine (2005) 99, 948 954 Concomitant upper-lobe bullous emphysema, lower-lobe interstitial fibrosis and pulmonary hypertension in heavy smokers: report of eight cases and review of the literature

More information

Systemic lupus erythematosus (SLE): Pleuropulmonary Manifestations

Systemic lupus erythematosus (SLE): Pleuropulmonary Manifestations 08/30/10 09/26/10 Systemic lupus erythematosus (SLE): Pleuropulmonary Manifestations Camila Downey S. Universidad de Chile, School of Medicine, Year VII Harvard University, School of Medicine Sept 17,

More information

Combined Unclassifiable Interstitial Pneumonia and Emphysema: A Report of Two Cases

Combined Unclassifiable Interstitial Pneumonia and Emphysema: A Report of Two Cases CASE REPORT Combined Unclassifiable Interstitial Pneumonia and Emphysema: A Report of Two Cases Nobuhiko Nagata 1, Kentaro Watanabe 2, Michihiro Yoshimi 3, Hiroshi Okabayashi 4, Katsuo Sueishi 5, Kentaro

More information

Lung Allograft Dysfunction

Lung Allograft Dysfunction Lung Allograft Dysfunction Carlos S. Restrepo M.D. Ameya Baxi M.D. Department of Radiology University of Texas Health San Antonio Disclaimer: We do not have any conflict of interest or financial gain to

More information

INTERSTITIAL LUNG DISEASE Dr. Zulqarnain Ashraf

INTERSTITIAL LUNG DISEASE Dr. Zulqarnain Ashraf Indep Rev Jul-Dec 2018;20(7-12) Dr. Zulqarnain Ashraf IR-653 Abstract: ILD is a group of diseases affect interstitium of the lung. Repeated insult to the lung cause the interstitium to be damaged. Similarly

More information

Idiopathic interstitial pneumonias (IIPs) are a group of

Idiopathic interstitial pneumonias (IIPs) are a group of SYMPOSIA C. Isabela S. Silva, MD, PhD and Nestor L. Müller, MD, PhD Abstract: The idiopathic interstitial pneumonias (IIPs) are a group of diffuse parenchymal lung diseases of unknown etiology characterized

More information

4/17/2010 C ini n ca c l a Ev E a v l a ua u t a ion o n of o ILD U dat a e t e i n I LDs

4/17/2010 C ini n ca c l a Ev E a v l a ua u t a ion o n of o ILD U dat a e t e i n I LDs Update in ILDs Diagnosis 101: Clinical Evaluation April 17, 2010 Jay H. Ryu, MD Mayo Clinic, Rochester MN Clinical Evaluation of ILD Outline General aspects of ILDs Classification of ILDs Clinical evaluation

More information

Challenges in the Diagnosis of Interstitial Lung Disease

Challenges in the Diagnosis of Interstitial Lung Disease Challenges in the Diagnosis of Interstitial Lung Disease Kirk D. Jones, MD UCSF Dept. of Pathology kirk.jones@ucsf.edu Overview New Classification of IIP Prior classification Modifications for new classification

More information

Anatomy and Physiology of the Lungs

Anatomy and Physiology of the Lungs The lungs consist of right and left sides. The right lung has three lobes: Upper lobe, Middle lobe, Lower lobe The left lung has two lobes: Upper lobe, Lower lobe Anatomy and Physiology of the Lungs The

More information

Progress in Idiopathic Pulmonary Fibrosis

Progress in Idiopathic Pulmonary Fibrosis Progress in Idiopathic Pulmonary Fibrosis David A. Lynch, MB Disclosures Progress in Idiopathic Pulmonary Fibrosis David A Lynch, MB Consultant: t Research support: Perceptive Imaging Boehringer Ingelheim

More information

Interstitial Lung Disease

Interstitial Lung Disease Interstitial Lung Disease Interstitial lung disease (ILD) is a broad category of lung diseases that includes more than 130 disorders which are characterized by scarring (i.e. fibrosis ) and/or inflammation

More information

an inflammation of the bronchial tubes

an inflammation of the bronchial tubes BRONCHITIS DEFINITION Bronchitis is an inflammation of the bronchial tubes (or bronchi), which are the air passages that extend from the trachea into the small airways and alveoli. Triggers may be infectious

More information

ARDS - a must know. Page 1 of 14

ARDS - a must know. Page 1 of 14 ARDS - a must know Poster No.: C-1683 Congress: ECR 2016 Type: Authors: Keywords: DOI: Educational Exhibit M. Cristian; Turda/RO Education and training, Edema, Acute, Localisation, Education, Digital radiography,

More information

Epidemiology and classification of smoking related interstitial lung diseases

Epidemiology and classification of smoking related interstitial lung diseases Epidemiology and classification of smoking related interstitial lung diseases Šterclová M. Department of Respiratory Diseases, Thomayer Hospital, Prague, Czech Republic Supported by an IGA Grant No G 1207

More information

DISEASES OF THE RESPIRATORY SYSTEM LECTURE 5 DR HEYAM AWAD FRCPATH

DISEASES OF THE RESPIRATORY SYSTEM LECTURE 5 DR HEYAM AWAD FRCPATH DISEASES OF THE RESPIRATORY SYSTEM LECTURE 5 DR HEYAM AWAD FRCPATH RESTRICTIVE, INTERSTITIAL LUNG DISESAES. FIROSING DISESES. GRANULOMATOUS DISEASES. EOSINOPHILIC. SMOKING RELATED. FIBROSING DISEASES

More information

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Medical Policy An independent licensee of the Blue Cross Blue Shield Association Idiopathic Pulmonary Fibrosis Page 1 of 10 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Idiopathic Pulmonary Fibrosis (Esbriet /pirfenidone, Ofev /nintedanib)

More information

I have no relevant conflicts of interest to disclose

I have no relevant conflicts of interest to disclose I have no relevant conflicts of interest to disclose Diffuse parenchymal lung disease (DPLD) and its associations Secondary lobular anatomy DPLD History, clinical findings, temporal evolution, and exposures

More information

Parenchymal, Interstitial i (Restrictive) i and Vascular Diseases

Parenchymal, Interstitial i (Restrictive) i and Vascular Diseases Pulmonary Diseases: Structure-Function Correlation II Parenchymal, Interstitial i (Restrictive) i and Vascular Diseases Alain C. Borczuk, M.D. Dept of Pathology Pulmonary Diseases: Structure-Function Correlation

More information

COPD and other lung conditions

COPD and other lung conditions COPD and other lung conditions COPD COPD is an umbrella term used to describe a collection of lung diseases including emphysema and chronic bronchitis. C Chronic - long term condition O Obstructive - difficulty

More information

Chronic obstructive lung disease. Dr/Rehab F.Gwada

Chronic obstructive lung disease. Dr/Rehab F.Gwada Chronic obstructive lung disease Dr/Rehab F.Gwada Obstructive lung diseases Problem is in the expiratory phase Lung disease Restrictive lung disease Restriction may be with, or within the chest wall Problem

More information

Connective Tissue Disorder- Associated Interstitial Lung Disease (CTD-ILD) and Updates

Connective Tissue Disorder- Associated Interstitial Lung Disease (CTD-ILD) and Updates Connective Tissue Disorder- Associated Interstitial Lung Disease (CTD-ILD) and Updates Maria Elena Vega, M.D Assistant Professor of Medicine Lewis Katz School of Medicine at Temple University Nothing to

More information

Respiratory Pathology. Kristine Krafts, M.D.

Respiratory Pathology. Kristine Krafts, M.D. Respiratory Pathology Kristine Krafts, M.D. Normal lung: alveolar spaces Respiratory Pathology Outline Acute respiratory distress syndrome Obstructive lung diseases Restrictive lung diseases Vascular

More information

T he diagnostic evaluation of a patient with

T he diagnostic evaluation of a patient with 546 REVIEW SERIES Challenges in pulmonary fibrosis? 1: Use of high resolution CT scanning of the lung for the evaluation of patients with idiopathic interstitial pneumonias Michael B Gotway, Michelle M

More information

SESSION 1: GENERAL (BASIC) PATHOLOGY CONCEPTS Thursday, October 16, :30am - 11:30am FACULTY COPY

SESSION 1: GENERAL (BASIC) PATHOLOGY CONCEPTS Thursday, October 16, :30am - 11:30am FACULTY COPY SESSION 1: GENERAL (BASIC) PATHOLOGY CONCEPTS Thursday, October 16, 2008 9:30am - 11:30am FACULTY COPY GOAL: Describe the basic morphologic (structural) changes which occur in various pathologic conditions.

More information

Overview of Idiopathic Pulmonary Fibrosis: Diagnosis and Therapy

Overview of Idiopathic Pulmonary Fibrosis: Diagnosis and Therapy Overview of Idiopathic Pulmonary Fibrosis: Diagnosis and Therapy Jeff Swigris, DO, MS Director, ILD Program National Jewish Health Disclosures Speaker - Boehringer Ingelheim and Genentech Objectives Describe

More information

Careful histopathological evaluation has shown the traditionally clinical diagnosis of

Careful histopathological evaluation has shown the traditionally clinical diagnosis of Demystifying Idiopathic Interstitial Pneumonia Harold R. Collard, MD; Talmadge E. King, Jr, MD REVIEW ARTICLE Careful histopathological evaluation has shown the traditionally clinical diagnosis of idiopathic

More information

Hypersensitivity Pneumonitis: Spectrum of High-Resolution CT and Pathologic Findings

Hypersensitivity Pneumonitis: Spectrum of High-Resolution CT and Pathologic Findings CT of Hypersensitivity Pneumonitis Chest Imaging Pictorial Essay C. Isabela S. Silva 1 ndrew Churg 2 Nestor L. Müller 1 Silva CIS, Churg, Müller NL Keywords: high-resolution CT, hypersensitivity pneumonitis,

More information

CTD-related Lung Disease

CTD-related Lung Disease 13 th Cambridge Chest Meeting King s College, Cambridge April 2015 Imaging of CTD-related Lung Disease Dr Sujal R Desai King s College Hospital, London Disclosure Statement No Disclosures / Conflicts of

More information

Criteria for confident HRCT diagnosis of usual interstitial pneumonia (UIP)

Criteria for confident HRCT diagnosis of usual interstitial pneumonia (UIP) Criteria for confident HRCT diagnosis of usual interstitial pneumonia (UIP) Assem El Essawy (1) & Amr A. Nassef (٢) Abstract Identification of interstitial pneumonia (IP) was mainly based on histological

More information

Daria Manos RSNA 2016 RC 401. https://medicine.dal.ca/departments/depar tment-sites/radiology/contact/faculty/dariamanos.html

Daria Manos RSNA 2016 RC 401. https://medicine.dal.ca/departments/depar tment-sites/radiology/contact/faculty/dariamanos.html Daria Manos RSNA 2016 RC 401 https://medicine.dal.ca/departments/depar tment-sites/radiology/contact/faculty/dariamanos.html STEP1: Is this fibrotic lung disease? STEP 2: Is this a UIP pattern? If yes:

More information

Interstitial Lung Disease in Infants and Children

Interstitial Lung Disease in Infants and Children Interstitial Lung Disease in Infants and Children David A. Mong, MD SUNDAY Andrew Mong MD Beyond the interstitium (path includes airways/airspace) Radiographic diffuse disease Adult Interstitial Lung Disease

More information

Radiological features of idiopathic interstitial pneumonia: a pictorial review

Radiological features of idiopathic interstitial pneumonia: a pictorial review Radiological features of idiopathic interstitial pneumonia: a pictorial review Poster No.: C-2012 Congress: ECR 2013 Type: Educational Exhibit Authors: M. Piccoli, F. Roccasalva, S. Palmucci, G. Cappello,

More information

Diagnostic challenges in IPF

Diagnostic challenges in IPF Medicine, Nursing and Health Sciences Diagnostic challenges in IPF Dr Ian Glaspole Central and Eastern Clinical School, Alfred Hospital and Monash University March 2015 Disclosures Consultancy fees from

More information

The crazy-paving pattern: A radiological-pathological correlated and illustrated overview

The crazy-paving pattern: A radiological-pathological correlated and illustrated overview The crazy-paving pattern: A radiological-pathological correlated and illustrated overview Poster No.: C-0827 Congress: ECR 2010 Type: Educational Exhibit Topic: Chest Authors: W. F. M. De Wever, J. Coolen,

More information

Prognostic Significance of Histopathologic Subsets in Idiopathic Pulmonary Fibrosis

Prognostic Significance of Histopathologic Subsets in Idiopathic Pulmonary Fibrosis Prognostic Significance of Histopathologic Subsets in Idiopathic Pulmonary Fibrosis JULIE A. BJORAKER, JAY H. RYU, MARK K. EDWIN, JEFFREY L. MYERS, HENRY D. TAZELAAR, DARRELL R. SCHROEDER, and KENNETH

More information

New lung lesion in a 55 year-old male treated with chemoradiation for non-small cell lung carcinoma

New lung lesion in a 55 year-old male treated with chemoradiation for non-small cell lung carcinoma July 2016 New lung lesion in a 55 year-old male treated with chemoradiation for non-small cell lung carcinoma Contributed by: Laurel Rose, MD, Resident Physician, Indiana University School of Medicine,

More information

PULMONARY MEDICINE BOARD REVIEW. Financial Conflicts of Interest. Question #1: Question #1 (Cont.): None. Christopher H. Fanta, M.D.

PULMONARY MEDICINE BOARD REVIEW. Financial Conflicts of Interest. Question #1: Question #1 (Cont.): None. Christopher H. Fanta, M.D. PULMONARY MEDICINE BOARD REVIEW Christopher H. Fanta, M.D. Pulmonary and Critical Care Division Brigham and Women s Hospital Partners Asthma Center Harvard Medical School Financial Conflicts of Interest

More information

Smoking-related Interstitial Lung Diseases: High-Resolution CT Findings

Smoking-related Interstitial Lung Diseases: High-Resolution CT Findings Smoking-related Interstitial Lung Diseases: High-Resolution CT Findings Poster No.: C-2358 Congress: ECR 2013 Type: Educational Exhibit Authors: V. Cuartero Revilla, M. Nogueras Carrasco, P. Olmedilla

More information

Overview of COPD INTRODUCTION

Overview of COPD INTRODUCTION Overview of COPD INTRODUCTION Chronic obstructive pulmonary disease (COPD) is a common lung disease that affects millions of people, and it is the fourth leading cause of death in the United States. It

More information

Case 1: Question. 1.1 What is the main pattern of this HRCT? 1. Intralobular line 2. Groundglass opacity 3. Perilymphatic nodule

Case 1: Question. 1.1 What is the main pattern of this HRCT? 1. Intralobular line 2. Groundglass opacity 3. Perilymphatic nodule HRCT WORK SHOP Case 1 Case 1: Question 1.1 What is the main pattern of this HRCT? 1. Intralobular line 2. Groundglass opacity 3. Perilymphatic nodule Case 1: Question 1.2 What is the diagnosis? 1. Hypersensitivity

More information

Diffuse Interstitial Lung Diseases: Is There Really Anything New?

Diffuse Interstitial Lung Diseases: Is There Really Anything New? : Is There Really Anything New? Sujal R. Desai, MBBS, MD ESTI SPEAKER SUNDAY Society of Thoracic Radiology San Antonio, Texas March 2014 Diffuse Interstitial Lung Disease The State of Play DILDs Is There

More information

Alpha-1 Antitrypsin Deficiency Alpha-1 Lung Disease

Alpha-1 Antitrypsin Deficiency Alpha-1 Lung Disease Alpha-1 Antitrypsin Deficiency Alpha-1 Lung Disease Chronic obstructive pulmonary disease (COPD) affects millions of people each year. Chronic means long term, obstructive means it is hard to get air in

More information

Thoracic lung involvement in rheumatoid arthritis: Findings on HRCT

Thoracic lung involvement in rheumatoid arthritis: Findings on HRCT Thoracic lung involvement in rheumatoid arthritis: Findings on HRCT Poster No.: C-2488 Congress: ECR 2015 Type: Educational Exhibit Authors: R. E. Correa Soto, M. J. Martín Sánchez, J. M. Fernandez 1 1

More information

Comments to the U.S. Food and Drug Administration Regarding the Patient-Focused Drug Development Re: Docket No. FDA-2012-N-0967

Comments to the U.S. Food and Drug Administration Regarding the Patient-Focused Drug Development Re: Docket No. FDA-2012-N-0967 Comments to the U.S. Food and Drug Administration Regarding the Patient-Focused Drug Development Re: Docket No. FDA-2012-N-0967 The American Lung Association welcomes the opportunity to comment on the

More information

Lung Disease Case Notes

Lung Disease Case Notes Lung Disease Case Notes Research the following diseases to find the description and symptoms of each disease. Then read the case notes and classify each as either Lung Disease, Emphysema, Fibrosis, Asthma

More information

Interesting Cases. Pulmonary

Interesting Cases. Pulmonary Interesting Cases Pulmonary 54M with prior history of COPD, hep B/C, and possible history of TB presented with acute on chronic dyspnea, and productive cough Hazy opacity overlying the left hemithorax

More information

Chest imaging II. Interstitial lung diseases

Chest imaging II. Interstitial lung diseases Chest imaging II. Interstitial lung diseases Dávid L. Tárnoki MD, PhD Ádám D. TárnokiMD, PhD Department of Radiology Semmelweis University Topics 1. Interstitial lung diseases 2. Occupational lung diseases

More information

IPF: Epidemiologia e stato dell arte

IPF: Epidemiologia e stato dell arte IPF: Epidemiologia e stato dell arte Clinical Classification Diffuse parenchimal lung diseases Exposure-related: - occupational - environmental - medication Desquamative interstitial pneumonia Idiopathic

More information

Nonspecific interstitial pneumonia and usual interstitial pneumonia: comparison of the clinicopathologic features and prognosis

Nonspecific interstitial pneumonia and usual interstitial pneumonia: comparison of the clinicopathologic features and prognosis Original Article Nonspecific interstitial pneumonia and usual interstitial pneumonia: comparison of the clinicopathologic features and prognosis Xia Li 1, Chang Chen 2, Jinfu Xu 1, Jinming Liu 1, Xianghua

More information

September 2014 Imaging Case of the Month. Michael B. Gotway, MD. Department of Radiology Mayo Clinic Arizona Scottsdale, AZ

September 2014 Imaging Case of the Month. Michael B. Gotway, MD. Department of Radiology Mayo Clinic Arizona Scottsdale, AZ September 2014 Imaging Case of the Month Michael B. Gotway, MD Department of Radiology Mayo Clinic Arizona Scottsdale, AZ Clinical History: A 57-year-old non-smoking woman presented to her physician as

More information

Hypersensitivity Pneumonitis Common Diagnostic and Treatment Dilemmas

Hypersensitivity Pneumonitis Common Diagnostic and Treatment Dilemmas Hypersensitivity Pneumonitis Common Diagnostic and Treatment Dilemmas Rishi Raj MD Director, Interstitial Lung Diseases Program Clinical Professor of Pulmonary and Critical Care Medicine Stanford University

More information

Unit II Problem 2 Pathology: Pneumonia

Unit II Problem 2 Pathology: Pneumonia Unit II Problem 2 Pathology: Pneumonia - Definition: pneumonia is the infection of lung parenchyma which occurs especially when normal defenses are impaired such as: Cough reflex. Damage of cilia in respiratory

More information

The Egyptian Journal of Hospital Medicine (July 2017) Vol.68 (2), Page

The Egyptian Journal of Hospital Medicine (July 2017) Vol.68 (2), Page The Egyptian Journal of Hospital Medicine (July 2017) Vol.68 (2), Page 1135-1140 Role of High Resolution Computed Tomography in Diagnosis of Interstitial Lung Diseases in Patients with Collagen Diseases

More information

Respiratory System. Organization of the Respiratory System

Respiratory System. Organization of the Respiratory System Respiratory System In addition to the provision of oxygen and elimination of carbon dioxide, the respiratory system serves other functions, as listed in (Table 15 1). Respiration has two quite different

More information

CLEARING THE AIR ON DIFFUSE PARENCHYMAL (INTERSTITIAL) LUNG DISEASE (ILD)

CLEARING THE AIR ON DIFFUSE PARENCHYMAL (INTERSTITIAL) LUNG DISEASE (ILD) CLEARING THE AIR ON DIFFUSE PARENCHYMAL (INTERSTITIAL) LUNG DISEASE (ILD) David Northrop MBA, RRT Assistant Director of Respiratory Therapy Services The University of Kansas Health System Clinical Assistant

More information

Imaging: how to recognise idiopathic pulmonary fibrosis

Imaging: how to recognise idiopathic pulmonary fibrosis REVIEW IDIOPATHIC PULMONARY FIBROSIS Imaging: how to recognise idiopathic pulmonary fibrosis Anand Devaraj Affiliations: Dept of Radiology, St George s Hospital, London, UK. Correspondence: Anand Devaraj,

More information

Northumbria Healthcare NHS Foundation Trust. Bronchiectasis. Issued by Respiratory Medicine

Northumbria Healthcare NHS Foundation Trust. Bronchiectasis. Issued by Respiratory Medicine Northumbria Healthcare NHS Foundation Trust Bronchiectasis Issued by Respiratory Medicine The aim of this booklet is to help you manage your bronchiectasis. It contains information which you should find

More information

Pediatric High-Resolution Chest CT

Pediatric High-Resolution Chest CT Pediatric High-Resolution Chest CT Alan S. Brody, MD Professor of Radiology and Pediatrics Chief, Thoracic Imaging Cincinnati Children s s Hospital Cincinnati, Ohio, USA Pediatric High-Resolution CT Short

More information